2020
DOI: 10.1016/j.intimp.2020.106266
|View full text |Cite
|
Sign up to set email alerts
|

UM171 promotes expansion of autologous peripheral blood hematopoietic stem cells from poorly mobilizing lymphoma patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 25 publications
0
7
0
Order By: Relevance
“…To identify dominant cell types of each sample library, the scRNA-seq-based cell type recognition tool SingleR (version 1.0.6) was repurposed and applied to the bulk RNA-seq dataset at hand (Aran et al, 2019). Default parameters were used to compute the correlation of each sample against the curated ImmGen reference dataset (Jojic et al, 2013;Shay and Kang, 2013;Aguilar et al, 2020). In particular, subtypes within the broad hematopoietic stem cell compartment were used as reference.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To identify dominant cell types of each sample library, the scRNA-seq-based cell type recognition tool SingleR (version 1.0.6) was repurposed and applied to the bulk RNA-seq dataset at hand (Aran et al, 2019). Default parameters were used to compute the correlation of each sample against the curated ImmGen reference dataset (Jojic et al, 2013;Shay and Kang, 2013;Aguilar et al, 2020). In particular, subtypes within the broad hematopoietic stem cell compartment were used as reference.…”
Section: Discussionmentioning
confidence: 99%
“…Despite significant increases in functional HSCs, these strategies uniformly required genetic integration, resulting in a risk of leukemic initiation via over-activation of self-renewal programs or blockage of differentiation. To overcome this, numerous groups have explored transient use of extrinsic regulators such as hematopoietic cytokines, growth factors and small molecules to increase HSC self-renewal (Zhang and Lodish, 2009; Fares et al , 2014; Wohrer et al , 2014; Wen et al , 2020). These efforts have culminated in a fully defined culture system that expands mouse HSCs >200-fold over a 28-day period (Wilkinson et al , 2019).…”
Section: Introductionmentioning
confidence: 99%
“…Despite significant increases in functional HSCs, these strategies uniformly required genetic integration, resulting in a risk of leukemic initiation via over‐activation of self‐renewal programs or blockage of differentiation. To overcome this, numerous groups have explored transient use of extrinsic regulators such as hematopoietic cytokines, growth factors, and small molecules to increase HSC self‐renewal (Zhang & Lodish, 2008 ; Fares et al , 2014 ; Wohrer et al , 2014 ; Wen et al , 2020 ). These efforts have culminated in a fully defined culture system that expands mouse HSCs > 200‐fold over a 28‐day period (Wilkinson et al , 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…A study explored the culture of hPSC-HPs in HSC expansion conditions. In the presence of THPO, SCF, FLT3L, IL3 and IL-6, the UM171-expanded is a specialized phenotype CD34+CD41aloCD45+ and was enriched in granulocytic progenitors (G-CFCs) [ 62 ]. However, in the cultures with SCF, FLT3L and IL7, UM171 selectively amplified the CD34+CD45+CD7+ phenotype with NK cells [ 60 ].…”
Section: Ex Vivo Expansion Of Hscsmentioning
confidence: 99%